Shares of Eastman Kodak (NYSE: KODK) are up two-thirds so far this week after a special committee set up by the company’s board found no lawbreaking in controversial stock trades made by top management in the leadup to announcing a $765 million federal government loan to support a shift to pharmaceutical manufacturing. Get the full […]
Monteris Medical raises $9M
Monteris Medical (Plymouth, Minn.) has raised another $9 million, about four months after it crossed the 3,000 mark of people treated with its NeuroBlate robot-assisted brain surgery device. The money came from a single investor, according to the Form D that Monteris filed today with the U.S. Securities and Exchange Commission. The company has been […]
Abbott wins EUA for COVID-19 test that runs off a card
FDA has announced an emergency use authorization for Abbott’s BinaxNow COVID-19 Ag Card — a speedy antigen test for the virus that can be directly read off the testing card. The agency in the announcement yesterday evening compared the test’s design to some pregnancy tests. A healthcare provider swabs the patient’s nose and twirls the […]
CMS proposes coverage updates that could increase access to VADs
The Centers for Medicare & Medicaid Services (CMS) today proposed coverage policy updates meant to increase access to VADs and artificial hearts. The policy updates, if approved, could be good news for major VAD makers Abbott (NYSE:ABT) and Medtronic (NYSE:MDT) — as well as people with heart failure who are waiting for a heart transplant or don’t […]
Theranos founder Elizabeth Holmes’ trial to start in March
Ex-Theranos CEO Elizabeth Holmes’ federal fraud trial will now start in March 2021 amid delays related to the COVID-19 pandemic. Judge Edward Davila decided yesterday that jury selection will start on March 9, with opening arguments taking place around March 16 in U.S. District Court in San Jose, Calif. It is possible that some or […]
Theranos founder Elizabeth Holmes is questioning grand jury selection process
Prosecutors are asking a federal judge to mostly deny ex-Theranos CEO Elizabeth Holmes’ request to inspect grand jury selection records. Holmes, according to the prosecutors’ July 31 response to Holmes’ July 30 motion, is adopting a strategy of other defendants indicted during the COVID-19 pandemic — to suggest without basis that was the grand jury […]
Siemens Healthineers to buy Varian for $16.4b
Siemens Healthineers (ETR: SHL) will acquire Varian Medical Systems (NYSE:VAR) in a $16.4 billion deal to create what the companies say will be the most comprehensive cancer care portfolio in the industry. SHL shares closed down –8.95% to €40.02 apiece in trading in Germany today, while VAR shares are up 21.61% to $173.57 apiece as of midday NYSE […]
Hologic blasts American Cancer Society over new Pap test guidelines
Hologic (NSDQ:HOLX) — a major company in the Pap and human papillomavirus (HPV) testing space — is criticizing the American Cancer Society over new cervical cancer screening recommendations that prefer simply doing HPV tests every five years. “Although all the screening tests are good at finding cancer and pre-cancer, primary HPV testing is better at finding […]
Smith+Nephew misses expectations in Q2
Smith+Nephew (LON:SN) today reported Q2 results that missed the consensus forecast of analysts as the COVID-19 pandemic drove revenue down nearly 30%, to $901 million. The British orthopedics, sports medicine and wound care products company, however, also reported that it saw elective procedures resume across the U.S. and much of Europe by the time the quarter […]
Aetna accuses Conformis of trying to use patient’s lawsuit to compel coverage
Joint replacement implant maker Conformis (NSDQ:CFMS) is improperly using a Colorado man’s denial of benefits lawsuit to force Aetna to cover its customized knee implants, the health insurer recently argued in a federal court filing. Billerica, Mass.-based Conformis joined John Michael Schaub of Golden, Colo., in his lawsuit against Aetna, filed in May in U.S. District Court […]
FDA clears Ambu single-use duodenoscope
Ambu announced today that FDA has cleared its aScope Duodeno — a sterile, single-use duodenoscope meant to avoid the deadly superbug outbreaks that cropped up around reusable versions of the scopes. Other companies — including Boston Scientific (NYSE:BSX), Hoya’s (TYO:7741) Pentax subsidiary, and Olympus (TYO:7733) — have been releasing either fully disposable duodenoscopes or duodenoscopes with disporable endcaps […]
- 1
- 2
- 3
- …
- 1559
- Next Page »
